Dmitri is a Scientific Advisor to Engage Bio. He is the CSO of Crossbow Therapeutics, where he is developing TCR-mimetic antibodies. He was previously CSO at Jounce Therapeutics, and Global Head of Immuno-Oncology at Sanofi. Dmitri received a PhD in cancer biology from Harvard University.